The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes.

The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes.

Item
http://www.wikidata.org/entity/Q34506434
Characterization of tau oligomeric seeds in progressive supranuclear palsy.Insulin resistance in Alzheimer's disease.Structure and mechanism of action of tau aggregation inhibitors.Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathyImmunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal lossTau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.Invited review: Drug development for tauopathies.Potential mechanisms and implications for the formation of tau oligomeric strains.Force spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers.Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons.Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice.Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.
P2860

The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes.

Item
http://www.wikidata.org/entity/Q34506434
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The formation of tau pore-like ...... ns for the disease phenotypes.
@ast
The formation of tau pore-like ...... ns for the disease phenotypes.
@en
The formation of tau pore-like ...... ns for the disease phenotypes.
@nl
type
label
The formation of tau pore-like ...... ns for the disease phenotypes.
@ast
The formation of tau pore-like ...... ns for the disease phenotypes.
@en
The formation of tau pore-like ...... ns for the disease phenotypes.
@nl
prefLabel
The formation of tau pore-like ...... ns for the disease phenotypes.
@ast
The formation of tau pore-like ...... ns for the disease phenotypes.
@en
The formation of tau pore-like ...... ns for the disease phenotypes.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
The formation of tau pore-like ...... ns for the disease phenotypes.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932